Literature DB >> 8043865

Coxsackievirus B3 infection in human leukocytes and lymphoid cell lines.

T Vuorinen1, R Vainionpää, H Kettinen, T Hyypiä.   

Abstract

Although coxsackie B viruses (CBVs) are known to cause viremia during acute infection, the role of the blood cells as a target for virus replication is poorly understood. We have analyzed the susceptibility of human peripheral blood mononuclear cells (PBMCs), granulocytes, bone marrow (BM) cells, and lymphoid cell lines to coxsackievirus B3 infection. Lymphoid cell lines with B- and T-cell characteristics (Raji and Molt-4, respectively) supported virus replication to high titers and virus protein synthesis was detected by metabolic labeling and immunoprecipitation. CBV3 synthesis in the U937 cell line with mononuclear phagocytic characteristics was very limited. The virus was able to infect a small proportion of leukocytes and BM cells, and intracellular virus antigens were detected by immunofluorescent staining. However, only a diminutive amount of infectious virus was produced in isolated PBMCs and granulocytes, and no virus protein synthesis was detected by metabolic labeling and immunoprecipitation in these cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043865

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers.

Authors:  D R Anderson; C M Carthy; J E Wilson; D Yang; D V Devine; B M McManus
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation.

Authors:  P A Benton; D J Barrett; R L Matts; R E Lloyd
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis.

Authors:  D R Anderson; J E Wilson; C M Carthy; D Yang; R Kandolf; B M McManus
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Acanthamoeba castellanii promotion of in vitro survival and transmission of coxsackie b3 viruses.

Authors:  A Mattana; C Serra; E Mariotti; G Delogu; P L Fiori; P Cappuccinelli
Journal:  Eukaryot Cell       Date:  2006-04

5.  Susceptibility of human bone marrow cells and hematopoietic cell lines to coxsackievirus B3 infection.

Authors:  T Vuorinen; R Vainionpää; R Vanharanta; T Hyypiä
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets.

Authors:  K Klingel; S Stephan; M Sauter; R Zell; B M McManus; B Bültmann; R Kandolf
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis.

Authors:  Mary Anne Opavsky; Tami Martino; Marlene Rabinovitch; Josef Penninger; Chris Richardson; Martin Petric; Cathy Trinidad; Lisa Butcher; Janice Chan; Peter P Liu
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

8.  Calpain 1 and 2 are required for RNA replication of echovirus 1.

Authors:  Paula Upla; Varpu Marjomäki; Liisa Nissinen; Camilla Nylund; Matti Waris; Timo Hyypiä; Jyrki Heino
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

9.  Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.

Authors:  Alain Haddad; M Reza Nokhbeh; David A Alexander; Sandra J Dawe; Christine Grisé; Naveed Gulzar; Kenneth Dimock
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors.

Authors:  Nadine Althof; J Lindsay Whitton
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.